Pharmacological modulation of adrenergic tone alters the vasodilatory response to passive leg movement in young but not in old adults
Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors...
Saved in:
Published in | Journal of applied physiology (1985) Vol. 134; no. 5; pp. 1124 - 1134 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.05.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 8750-7587 1522-1601 1522-1601 |
DOI | 10.1152/japplphysiol.00682.2022 |
Cover
Loading…
Abstract | Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α
1
-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC
Δpeak
) and total vasodilation (LVC
AUC
, area under curve) were documented. PROP decreased LVC
Δpeak
(PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg
−1
, P < 0.001) and LVC
AUC
(PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg
−1
, P = 0.002) in the young, but not in the old (LVC
Δpeak
, P = 0.931; LVC
AUC
, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min
−1
·mmHg
−1
, P < 0.01), LVC
Δpeak
(PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min
−1
·mmHg
−1
, P = 0.004), and LVC
AUC
(PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg
−1
, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC
Δpeak
, P = 0.904; LVC
AUC
, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC
Δpeak
was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min
−1
·mmHg
−1
, P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC
Δpeak
was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min
−1
·mmHg
−1
, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. |
---|---|
AbstractList | Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α
1
-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC
Δpeak
) and total vasodilation (LVC
AUC
, area under curve) were documented. PROP decreased LVC
Δpeak
(PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg
−1
, P < 0.001) and LVC
AUC
(PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg
−1
, P = 0.002) in the young, but not in the old (LVC
Δpeak
, P = 0.931; LVC
AUC
, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min
−1
·mmHg
−1
, P < 0.01), LVC
Δpeak
(PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min
−1
·mmHg
−1
, P = 0.004), and LVC
AUC
(PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg
−1
, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC
Δpeak
, P = 0.904; LVC
AUC
, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC
Δpeak
was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min
−1
·mmHg
−1
, P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC
Δpeak
was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min
−1
·mmHg
−1
, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α 1 -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC Δpeak ) and total vasodilation (LVC AUC , area under curve) were documented. PROP decreased LVC Δpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg −1 , P < 0.001) and LVC AUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg −1 , P = 0.002) in the young, but not in the old (LVC Δpeak , P = 0.931; LVC AUC , P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min −1 ·mmHg −1 , P < 0.01), LVC Δpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min −1 ·mmHg −1 , P = 0.004), and LVC AUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg −1 , P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC Δpeak , P = 0.904; LVC AUC , P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC Δpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min −1 ·mmHg −1 , P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC Δpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min −1 ·mmHg −1 , P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC ) and total vasodilation (LVC , area under curve) were documented. PROP decreased LVC (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg , < 0.001) and LVC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg , = 0.002) in the young, but not in the old (LVC , = 0.931; LVC , = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min ·mmHg , < 0.01), LVC (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min ·mmHg , = 0.004), and LVC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg , = 0.011) in the young, but not in the old (baseline LVC, = 0.199; LVC , = 0.904; LVC , = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: < 0.05), however LVC was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min ·mmHg , = 0.004), and not in the old ( = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVC was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min ·mmHg , = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg-1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg-1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min-1·mmHg-1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min-1·mmHg-1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg-1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min-1·mmHg-1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min-1·mmHg-1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg-1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg-1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min-1·mmHg-1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min-1·mmHg-1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg-1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min-1·mmHg-1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min-1·mmHg-1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg−1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg−1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min−1·mmHg−1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min−1·mmHg−1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg−1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min−1·mmHg−1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min−1·mmHg−1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. |
Author | Morgan, David E. Broxterman, Ryan M. Richardson, Russell S. Trinity, Joel D. Craig, Jesse C. Birgenheier, Nathaniel M. Wray, D. Walter Fermoyle, Caitlin C. Alpenglow, Jeremy K. La Salle, D. Taylor Jarrett, Catherine L. McKenzie, Alec I. |
Author_xml | – sequence: 1 givenname: Caitlin C. orcidid: 0000-0003-1027-7081 surname: Fermoyle fullname: Fermoyle, Caitlin C. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States – sequence: 2 givenname: D. Taylor surname: La Salle fullname: La Salle, D. Taylor organization: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States – sequence: 3 givenname: Jeremy K. surname: Alpenglow fullname: Alpenglow, Jeremy K. organization: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States – sequence: 4 givenname: Jesse C. orcidid: 0000-0001-5959-4139 surname: Craig fullname: Craig, Jesse C. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States – sequence: 5 givenname: Catherine L. orcidid: 0000-0001-5131-7858 surname: Jarrett fullname: Jarrett, Catherine L. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States – sequence: 6 givenname: Ryan M. orcidid: 0000-0002-7388-2214 surname: Broxterman fullname: Broxterman, Ryan M. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States – sequence: 7 givenname: Alec I. orcidid: 0000-0002-6336-8684 surname: McKenzie fullname: McKenzie, Alec I. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States – sequence: 8 givenname: David E. surname: Morgan fullname: Morgan, David E. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States – sequence: 9 givenname: Nathaniel M. surname: Birgenheier fullname: Birgenheier, Nathaniel M. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States – sequence: 10 givenname: D. Walter orcidid: 0000-0002-6907-1734 surname: Wray fullname: Wray, D. Walter organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States – sequence: 11 givenname: Russell S. surname: Richardson fullname: Richardson, Russell S. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States – sequence: 12 givenname: Joel D. orcidid: 0000-0001-8271-6536 surname: Trinity fullname: Trinity, Joel D. organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36927146$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1uEzEUhS3UiqaFVwBLbNhManv8M7NACFUtIFUqC1hbju1JHHnswfZEygPw3jhpqUo3XVny_e655-qec3ASYrAAvMdoiTEjl1s1TX7a7LOLfokQ78iSIEJegUWtkgZzhE_AohMMNYJ14gyc57xFCFPK8Gtw1vKeCEz5Avz5sVFpVDr6uHZaeThGM3tVXAwwDlCZZINNtQRLdQCVLzZlWDYW7lSOxlU0pj1MNk8xZFspOKmc3c5Cb9dVbWdHGwp0Ae7jHNZwNRcY4vEjelMHzL7kN-B0UD7btw_vBfh1c_3z6ltze_f1-9WX20ZTykujeluNG44oor3ighskCMdti4UhYhBC91j3rVGopWbghHFDWNtjuiKaWY3bC_D5XneaV6M1ujpLysspuVGlvYzKyf8rwW3kOu4kRpiwqloVPj4opPh7trnI0WVtvVfBxjlLIrqetILhw7APz9BtnFOo-0nSIcZIR7uuUu-eWnr08u9EFRD3gE4x52SHRwQjeQiDfBoGeQyDPIShdn561qldOZ627ub8i_1_AcxGwxM |
CitedBy_id | crossref_primary_10_14814_phy2_70180 |
Cites_doi | 10.1113/jphysiol.2003.054650 10.1016/0735-1097(95)00327-4 10.1152/japplphysiol.00557.2017.-As 10.1152/ajpheart.00649.2019 10.1152/ajpregu.00345.2018 10.1111/j.1469-7793.2001.00977.x 10.1113/jphysiol.2012.240093 10.1007/s40279-019-01146-1 10.1016/s0735-1097(00)00849-4 10.1113/jphysiol.2011.212753 10.1152/ajpheart.01115.2010 10.1152/ajpheart.00784.2020 10.1152/ajpheart.00482.2010 10.1113/jphysiol.1978.sp012170 10.1152/ajpheart.00422.2015 10.1161/01.HYP.21.4.498 10.1152/ajpheart.00771.2005 10.1177/1358863X15586473 10.1161/01.CIR.100.2.164 10.1152/ajpheart.00240.2006 10.1152/ajpheart.01396.2006 10.1152/ajpheart.01016.2008 10.1152/japplphysiol.00979.2001 10.1152/ajpheart.00806.2014 10.1113/EP089818 10.1113/EP089629 10.1113/JP273183 10.1152/japplphysiol.01120.2013 10.1161/CIRCULATIONAHA.110.953653 10.1113/jphysiol.2014.278358 10.1249/MSS.0000000000000782 10.1161/HYPERTENSIONAHA.119.12881 10.1113/JP270195 10.1161/01.CIR.0000028819.64790.BE 10.1152/ajpheart.00886.2015 10.1152/japplphysiol.00452.2021 10.1016/j.autneu.2022.102969 10.1113/jphysiol.2003.042747 10.1113/JP270946 10.1016/S0735-1097(01)01786-7 10.1152/japplphysiol.00110.2014 10.1161/01.HYP.32.1.9 10.1016/0735-1097(94)90627-0 10.1113/jphysiol.2010.198770 10.1161/01.HYP.32.2.298 10.1113/jphysiol.2011.224741 10.1152/ajpheart.00038.2011 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society May 2023 Published by the American Physiological Society |
Copyright_xml | – notice: Copyright American Physiological Society May 2023 – notice: Published by the American Physiological Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
DOI | 10.1152/japplphysiol.00682.2022 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Technology Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | PASSIVE LEG MOVEMENT AND ADRENERGIC TONE WITH AGE |
EISSN | 1522-1601 |
EndPage | 1134 |
ExternalDocumentID | PMC10125034 36927146 10_1152_japplphysiol_00682_2022 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: CSRD VA grantid: I01 CX001999 – fundername: NHLBI NIH HHS grantid: R01 HL142603 – fundername: NHLBI NIH HHS grantid: T32 HL007576 – fundername: RRD VA grantid: IK2 RX001215 – fundername: CSRD VA grantid: I01 CX002152 – fundername: NHLBI NIH HHS grantid: T32 HL139451 – fundername: ; grantid: T32 HL139451 – fundername: ; grantid: E9275-L – fundername: ; grantid: I01CX001999 – fundername: ; grantid: R01HL142603 – fundername: ; grantid: Advanced Fellowship in Geriatrics |
GroupedDBID | --- -~X .55 18M 29J 2WC 4.4 53G 5VS 85S AAFWJ AAYXX ABCQX ABDNZ ABHWK ABJNI ABKWE ABOCM ACBEA ACGFO ACGFS ACIWK ACPRK ADBBV ADFNX AEILP AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD EMOBN F5P FRP GX1 H13 H~9 ITBOX KQ8 L7B OK1 P2P P6G PQQKQ RAP RHI RPL RPRKH SJN TR2 UHB UKR UPT W8F WH7 WOQ X7M XSW YBH YQT YWH ~02 CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c446t-a9e692d604049a676d072613317d27f77c91c93da034df6256d253914b2c5ec13 |
ISSN | 8750-7587 1522-1601 |
IngestDate | Thu Aug 21 18:34:29 EDT 2025 Fri Sep 05 14:08:06 EDT 2025 Mon Jun 30 10:43:57 EDT 2025 Thu Apr 03 06:57:07 EDT 2025 Tue Jul 01 03:17:04 EDT 2025 Thu Apr 24 23:11:09 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | blood flow regulation vascular function vascular aging |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c446t-a9e692d604049a676d072613317d27f77c91c93da034df6256d253914b2c5ec13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1027-7081 0000-0002-6336-8684 0000-0001-5959-4139 0000-0002-7388-2214 0000-0001-5131-7858 0000-0002-6907-1734 0000-0001-8271-6536 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/10125034 |
PMID | 36927146 |
PQID | 2805528488 |
PQPubID | 40905 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10125034 proquest_miscellaneous_2789237511 proquest_journals_2805528488 pubmed_primary_36927146 crossref_primary_10_1152_japplphysiol_00682_2022 crossref_citationtrail_10_1152_japplphysiol_00682_2022 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-05-01 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda – name: Rockville, MD |
PublicationTitle | Journal of applied physiology (1985) |
PublicationTitleAlternate | J Appl Physiol (1985) |
PublicationYear | 2023 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | B20 B42 B21 B43 B22 B44 B23 B45 B24 B46 B25 B47 B26 B48 B27 B28 B29 B30 B31 B10 B32 B11 B33 B12 B34 B13 B35 B14 B36 B15 B37 B16 B38 B17 B39 B18 B19 B1 B2 B3 B4 B5 B6 B7 B9 B40 B41 |
References_xml | – ident: B27 doi: 10.1113/jphysiol.2003.054650 – ident: B9 doi: 10.1016/0735-1097(95)00327-4 – ident: B25 doi: 10.1152/japplphysiol.00557.2017.-As – ident: B40 doi: 10.1152/ajpheart.00649.2019 – ident: B28 doi: 10.1152/ajpregu.00345.2018 – ident: B3 doi: 10.1111/j.1469-7793.2001.00977.x – ident: B5 doi: 10.1113/jphysiol.2012.240093 – ident: B33 doi: 10.1007/s40279-019-01146-1 – ident: B35 doi: 10.1016/s0735-1097(00)00849-4 – ident: B34 doi: 10.1113/jphysiol.2011.212753 – ident: B6 doi: 10.1152/ajpheart.01115.2010 – ident: B18 doi: 10.1152/ajpheart.00784.2020 – ident: B31 doi: 10.1152/ajpheart.00482.2010 – ident: B43 doi: 10.1113/jphysiol.1978.sp012170 – ident: B29 doi: 10.1152/ajpheart.00422.2015 – ident: B42 doi: 10.1161/01.HYP.21.4.498 – ident: B38 doi: 10.1152/ajpheart.00771.2005 – ident: B39 doi: 10.1177/1358863X15586473 – ident: B2 doi: 10.1161/01.CIR.100.2.164 – ident: B16 doi: 10.1152/ajpheart.00240.2006 – ident: B23 doi: 10.1152/ajpheart.01396.2006 – ident: B44 doi: 10.1152/ajpheart.01016.2008 – ident: B41 doi: 10.1152/japplphysiol.00979.2001 – ident: B19 doi: 10.1152/ajpheart.00806.2014 – ident: B46 doi: 10.1113/EP089818 – ident: B24 doi: 10.1113/EP089629 – ident: B37 doi: 10.1113/JP273183 – ident: B22 doi: 10.1152/japplphysiol.01120.2013 – ident: B7 doi: 10.1161/CIRCULATIONAHA.110.953653 – ident: B45 doi: 10.1113/jphysiol.2014.278358 – ident: B21 doi: 10.1249/MSS.0000000000000782 – ident: B12 doi: 10.1161/HYPERTENSIONAHA.119.12881 – ident: B47 doi: 10.1113/JP270195 – ident: B30 doi: 10.1161/01.CIR.0000028819.64790.BE – ident: B36 doi: 10.1152/ajpheart.00886.2015 – ident: B48 doi: 10.1152/japplphysiol.00452.2021 – ident: B20 doi: 10.1016/j.autneu.2022.102969 – ident: B4 doi: 10.1113/jphysiol.2003.042747 – ident: B13 doi: 10.1113/JP270946 – ident: B15 doi: 10.1016/S0735-1097(01)01786-7 – ident: B14 doi: 10.1152/japplphysiol.00110.2014 – ident: B11 doi: 10.1161/01.HYP.32.1.9 – ident: B10 doi: 10.1016/0735-1097(94)90627-0 – ident: B26 doi: 10.1113/jphysiol.2010.198770 – ident: B1 doi: 10.1161/01.HYP.32.2.298 – ident: B17 doi: 10.1113/jphysiol.2011.224741 – ident: B32 doi: 10.1152/ajpheart.00038.2011 |
SSID | ssj0014451 |
Score | 2.4211636 |
Snippet | Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young.... The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However,... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1124 |
SubjectTerms | Adrenergic Agents - pharmacology Aged Blood flow Blood pressure Femoral artery Hemodynamics Humans Leg Leg - blood supply Modulation Movement - physiology Phentolamine Phenylephrine Regional Blood Flow - physiology Vasodilation Vasodilation - physiology |
Title | Pharmacological modulation of adrenergic tone alters the vasodilatory response to passive leg movement in young but not in old adults |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36927146 https://www.proquest.com/docview/2805528488 https://www.proquest.com/docview/2789237511 https://pubmed.ncbi.nlm.nih.gov/PMC10125034 |
Volume | 134 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCDYuhYGMhHiJCrk4dvI4VSvTNMYkWqlvkZO4o1KWVL1M6t75NfxJzrGdNB2dGLxErXOVz5eTc-zP3yHkg4oDNgHX2PNDiaNVUd5LPZnB6y6yPGUqhQ2yLc75yYidjsNxp_OrxVpaLdNP2c3OdSX_Y1VoA7viKtl_sGxzUWiA32Bf2IKFYXsvG19sdKd1X19Vua3GZab3Ua5yDrscVNx29MT4Qkea13JR5dPCzLDPDU1W19CYQSyNXKJCXcLVtJa4riGwRqfgpKulU1a6oSpyo92xuCO8lTa81UMnRugJNaHiKGwNPgzgu1CtDaO5jyV8cA1iwxGSznes9KLdomOGFhp8FjNVXhZmYupUzXFRTDNg25_LqeEZozC6vaAd2fBbPMLaGUOi7HHbpHa01R7cjodO25Pk2h9DNMl2fyhCXxcogL6w_YAMvwiX5pl10tvS3OffksHo7CwZHo-HD8hDXwjNCfgybvhEHiq9aXFe-4CWTAj_P99xm-1Q6I_85jZNtxX3DJ-SJ9ai9Mig7xnpqHKfHByVgJ2rNf1ILxr77pNHXy1T44D8vIVNusEmrSZ0g02K2KQGmxSwSdvYpDU24ShqsUkBm7TGJp2WVGOTAjYpYBMbAJvUYPM5GQ2Oh_2Tni350csY48uejBWP_ZzDp4XFkgueuwJy_ABcR-6LiRBZ7GVxkEs3YPkEcnee-2EQeyz1s1BlXvCC7JXw2K8IlUEgM0heeBZxxiVEXRJSI-G6iqdMiLhLeN37SWb18LEsS5HovDj0k7bZEm22BM3WJW5z4sxIwvz9lMPavIn1H4vEj9wwhOgwirrkfbMbvDtO2clSVSs4RkSQgQnIirrkpUFDc88AekpAoNMl0RZOmgNQOX57Tzn9oRXkUdQvhC58fY8bvyGPNy_nIdlbzlfqLQTiy_SdfgF-A8525tc |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacological+modulation+of+adrenergic+tone+alters+the+vasodilatory+response+to+passive+leg+movement+in+young+but+not+in+old+adults&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Fermoyle%2C+Caitlin+C&rft.au=La+Salle%2C+D+Taylor&rft.au=Alpenglow%2C+Jeremy+K&rft.au=Craig%2C+Jesse+C&rft.date=2023-05-01&rft.issn=1522-1601&rft.eissn=1522-1601&rft.volume=134&rft.issue=5&rft.spage=1124&rft_id=info:doi/10.1152%2Fjapplphysiol.00682.2022&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon |